Nolato Ab Class B · OMXSTO:NOLA_B
Nolato Ab Class B — Q2 2023 Earnings Presentation
15 slides from Nolato Ab Class B's earnings presentation, Jul 20, 2023
Slide 1: Second quarter
Medical Solutions Second quarter Integrated Solutions CEO Christer Wahlquist CFO Per-Ola Holmström Industrial Solutions July 20, 2023
Slide 2: Q2 summary
Q2 summary A global solutions provider established on three continents Group Growth across Group ● Sales totaled SEK 2,478 million (2,905) SEKm - Positive currency effect; a 20% decrease, adjusted for currency 12000 Balancing - Positive performance by Medical and Industrial Solutions but low volumes
Slide 3: One Group – three business areas
One Group – three business areas Nolato Medical Solutions Integrated Solutions Industrial Solutions Our offering as a strategic partner for selected Development and manufacture of Design, development and Development and manufacture of global customers comprises development and complex product system
Slide 4: Medical Solutions – Sustainable Growth and Global expansion
Medical Solutions – Sustainable Growth and Global expansion SEKm 5500 5000 4500 4000 3500 3000 138 EBITA 2500 2000 1,364 SEKm, Q2 1500 1000 10.1 SALES SEKm, Q2 500 EBITA-MARGIN 0 %, Q2 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 LTM 4
Slide 5: Medical Solutions – Focused product areas
Medical Solutions – Focused product areas Pharma Diagnostics Medical Devices Drug Delivery ~14% In Vitro Diagnostics (IVD) ~15% Endoscopy & General Surgery ~22% Cardiology ~8% Continence care ~11% Pharma Packaging ~13% Other ~17% 5
Slide 6: Medical Solutions – Q2
Medical Solutions – Q2 Q2 Acc. 6 months ● 12% increase in sales SEKm 2023 2022 2023 2022 - 6% increase, adjusted for currency - Good growth in most market areas Sales 1,364 1,214 2,688 2,302 - IVD at unchanged level due to inventory adjustments in the value chain ● EBITA margin of 10.1% (10.0) Opera
Slide 7: Integrated Solutions – Expansion into new market segments
Integrated Solutions – Expansion into new market segments SEKm 5500 5000 4500 4000 3500 16 EBITA 3000 2500 392 SEKm, Q2 2000 1500 4.1 SALES 1000 SEKm, Q2 500 EBITA-MARGIN %, Q2 0 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 LTM 7
Slide 8: Integrated Solutions – Focused product areas
Integrated Solutions – Focused product areas Consumer Electronics EMC & Thermal Trishield - Dispensing Gaskets Complex Modules Speakers Compashield - Extrusion & Molded Gaskets VHP MIL SPEC EMI Shielding In/On/Over Ear Headphones - Aerospace & Defence Wearable & Handheld Wellbeing Devices Thermal In
Slide 9: Integrated Solutions – Q2
Integrated Solutions – Q2 Q2 Acc. 6 months ● 62% decrease in sales - 63% decline, adjusted for currency SEKm 2023 2022 2023 2022 - Low volumes and a change in sourcing strategy at a previously significant customer had a negative impact Sales 392 1,019 806 2,159 - EMC sales increased to SEK 174 milli
Slide 10: Industrial Solutions – Technological and geographical expansion
Industrial Solutions – Technological and geographical expansion SEKm 2800 2600 2400 2200 2000 1800 1600 56 1400 1200 724 EBITA SEKm, Q2 1000 800 SALES 7.7 600 SEKm, Q2 400 EBITA-MARGIN 200 %, Q2 0 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 LTM 10
Slide 11: Industrial Solutions – Focused product areas
Industrial Solutions – Focused product areas Domestic appliances Packaging Hygiene Gardening/forestry Furniture sectors Automotive Other selected industrial segments 11
Slide 12: Industrial Solutions – Q2
Industrial Solutions – Q2 ● 7% increase in sales Q2 Acc. 6 months - 1% increase, adjusted for currency SEKm 2023 2022 2023 2022 - Volumes in automotive have risen and disruptions in the supply chain have had less of an impact than previously Sales 724 676 1,464 1,329 - Demand for products in consume
Slide 13: Group financial highlights
Group financial highlights Q2 Acc. 6 months Full year SEKm 2023 2022 2023 2022 R-12 2022 Net sales 2,478 2,905 4,954 5,784 9,944 10,774 Operating profit (EBITA) 198 264 391 531 768 908 EBITA margin (%) 8.0 9.1 7.9 9.2 7.7 8.4 Profit after financial income and expense 192 241 365 492 748 875 Profit a
Slide 14: Current situation
Current situation Medical Solutions Integrated Solutions Industrial Solutions • Maintained growth strategy • Established position in new product • Advanced market positions areas • Focus on innovation • Emphasis on sustainable solutions • Flexible production structure • Strong customer • Generally w
Slide 15: Thank you.
Thank you. This presentation may contain forward-looking statements. When used in this presentation, words such as “anticipate”, “believe”, “estimate”, “expect”, “plan” and “project” are intended to identify forward-looking statements. Such statements could encompass risks and uncertainties pertaini